Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Association Between Autologous Transfusion and Recurrence-free Survival in Patients With Hepatocellular Carcinoma After Resection-a Prospective Non-randomized Controlled Trial

NCT02654028 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT02654028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Association Between Autologous Transfusion and Recurrence-free Survival in Patients With Hepatocellular Carcinoma After Resection-a Prospective Non-randomized Controlled Trial
Lead sponsor
Guangxi Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2019
Completion date
December 30, 2021
Enrollment
618 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer